Press release

Amgen Joins American Kidney Fund's 2023 Corporate Membership Program at 'Champion' Level

The American Kidney Fund (AKF) expressed its appreciation for Amgen's participation in the 2023 class of its Corporate Membership Program as a Champion-level member.

Rockville, Md. (Sept. 6, 2023) — The American Kidney Fund (AKF) today expressed its appreciation for Amgen's participation in the 2023 class of its Corporate Membership Program as a Champion-level member. Amgen's membership will help fund AKF's work to advance kidney disease awareness, prevention, early detection, treatment and research, helping people living with or at risk for kidney disease live healthier lives.

"We are honored that Amgen has partnered with AKF for more than three decades now in the fight against kidney disease," said LaVarne A. Burton, AKF President and CEO. "With the funding they provide, Amgen continues to help the 37 million Americans living with kidney disease through patient-focused programming as well as financial assistance for dialysis patients affected by natural disasters to offset health care expenses."

As a Champion-level member, Amgen helps create AKF's educational initiatives like the secondary hyperparathyroidism (which is commonly caused by kidney failure) campaign, provides vital resources for clinical research aimed at improving health outcomes for people with kidney disease and supports programs for kidney health care professionals.

"Amgen is proud to help the American Kidney Fund with its mission to fight kidney disease, a life-changing group of illnesses impacting 1 in 7 Americans," said Ned Endler, Executive Director at Amgen. "We are pleased to support AKF in its creation of programs and resources on kidney disease management – both for health care professionals and the public – fighting this 'silent killer' disease on all fronts."

In addition to contributing to AKF's Disaster Relief Program, which provides emergency grants to dialysis and transplant patients affected by natural disasters, Amgen also supports AKF's annual national gala, The Hope Affair, which honors patients and caregivers who are dealing with kidney disease.

By joining the Corporate Membership Program, Amgen is helping to fund AKF's award-winning educational programs and resources.

The Corporate Membership Program is open to institutional partners that support AKF's mission of fighting kidney disease and helping people live healthier lives. For more information, contact Daniel Green, corporate engagement manager, at or 301-984-6675.

About the American Kidney Fund

The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. One of the nation’s top-rated nonprofits, AKF invests 97 cents of every donated dollar in programs, earning the highest 4-Star rating from Charity Navigator for 20 years in a row as well as the Platinum Seal of Transparency from Candid, formerly GuideStar.

For more information, please visit, or connect with us on Facebook, Twitter, Instagram and LinkedIn.